Science Current Events | Science News | Brightsurf.com
 

Research shows how 'Mallard' dye fills need for speed

February 15, 2013
Scientists at the University of York have developed a new medical tool which could help surgeons carrying out complex procedures in the operating theatre.

Researchers have developed a dye which provides a quick and accurate method of checking heparin levels in the blood.

Heparin is an important anti-coagulant which has a significant role in major surgery. The scientists in the Department of Chemistry at York have used inspiration from biological systems to allow the dye to bind heparin even in highly competitive human serum.

In the laboratory, they have modified existing dyes which previously could not bind with heparin successfully under these challenging conditions. The modified dye, which has excellent sensing capacity for heparin pinpoints the anti-coagulant's level in human serum and has the potential to work more quickly than existing clinical methods for doing this.

The research, which was funded by the Biotechnology and Biological Sciences Research Council, is published in the Journal of the American Chemical Society.

Because the dye can rapidly detect heparin levels, the scientists have named it 'Mallard Blue'. It is the same shade as the livery of the A4 Pacific Mallard, which holds the world speed record for a steam locomotive, and is now preserved at the National Railway Museum in York.

Professor Dave Smith, of the Department of Chemistry at York who led the research said: "Our new dye allows the quantification of heparin in serum at clinically relevant levels and is the best in class for this application in terms of its ability to bind heparin strongly under really competitive biological conditions, and may improve on the currently used systems.

"We have named the dye 'Mallard Blue', after the record-breaking steam train, 'Mallard' which is housed in the railway museum here at York. Our dye is the same colour as the locomotive, and we believe it is similarly ground-breaking in its performance."

The York researchers worked with a team led by Sabrina Pricl at the University of Trieste who used high-level computer modelling to understand precisely how Mallard Blue binds to heparin so strongly.

The next stage in this research would involve the incorporation of this new dye into a device for simple bedside read-out of heparin levels in blood.

University of York


Related Heparin Current Events and Heparin News Articles


Mechanical heart valves increase pregnancy risk
The fact that mechanical heart valves increase risks during and after pregnancy, has been confirmed by data from the ROPAC registry presented for the first time today in an ESC Congress Hot Line session by Professor Jolien W. Roos-Hesselink, co-chair with Professor Roger Hall of the registry's executive committee.

Best anticoagulants after orthopedic procedures depends on type of surgery
Current guidelines do not distinguish between aspirin and more potent blood thinners for protecting against blood clots in patients who undergo major orthopedic operations, leaving the decision up to individual clinicians.

The Lancet: New trial suggests cheaper drugs for common heart attack procedure could improve outcomes and save health budgets millions
A new study published in The Lancet compares outcomes for two drugs used to prevent blood clot formation during emergency heart attack treatment.

Unlocking the potential of stem cells to repair brain damage
A QUT scientist is hoping to unlock the potential of stem cells as a way of repairing neural damage to the brain.

Engineering a better way to rebuild bone inside the body
Traumatic bone injuries such as blast wounds are often so severe that the body can't effectively repair the damage on its own.

Researchers find new molecule to treat asthma
A new study carried out by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), the Max Planck Institute for Colloids and Interfaces (Germany), the Free University of Berlin (Germany), UC San Diego, and Shinshu University (Japan) has identified a novel molecule that prevents T-cells from orchestrating asthma brought on by allergens.

Heparin more effective than bivalirudin in patients during emergency heart procedure
In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major cardiovascular events at 28 days than bivalirudin in patients receiving primary percutaneous coronary intervention after a heart attack.

Repeated hUCB injections may improve prognosis of children with deadly inherited disorder
New insight has been gained into treating an inherited disorder that creates serious neurological and behavioral disabilities in children and usually leads to death in the teen years.

Antidote can deactivate new form of heparin
Low-molecular-weight heparin is commonly used in surgeries to prevent dangerous blood clots. But when patients experience the other extreme - uncontrolled bleeding - in response to low-molecular-weight heparin, there is no antidote.

A new treatment for heart attack will soon be available for emergency teams and the emergency ambulance
A new strategy for emergency anticoagulant treatment for patients with acute myocardial infarction has been put in place by a team led by Philippe-Gabriel Steg at Inserm Unit 698 (Haemostasis, Bioengineering, Immunopathology and Cardiovascular Remodelling), at Hôpital Bichat, AP-HP, Université Paris Diderot).
More Heparin Current Events and Heparin News Articles

Heparin-Induced Thrombocytopenia, Fifth Edition (Fundamental and Clinical Cardiology)

Heparin-Induced Thrombocytopenia, Fifth Edition (Fundamental and Clinical Cardiology)
by Theodore E. Warkentin (Editor), Andreas Greinacher (Editor)


Although first reported in 1973, immune heparin-induced thrombocytopenia (HIT) remains one of the most frequent and devastating adverse drug reactions encountered by physicians. This thoroughly updated fifth edition from international experts Professors Warkentin and Greinacher is the gold standard for accurate diagnosis and management of this condition. Identifying key signs and symptoms and providing clear intervention strategies—including the use of alternative anticoagulants to manage critical circumstances—this is an essential resource for all clinicians and a "must" for hematology consultants. Heparin-Induced Thrombocytopenia, Fifth Edition explores: Clinical and laboratory studies on HIT The immune basis and pathogenesis, animal models, and laboratory testing for HIT...

Heparin

Heparin


Heparin

Target audience: Medical students, residents, healthcare workers, patients
Weekly updates? Yes
Multiple choice questions? Yes
Board review? Yes

Heparin-Induced Thrombocytopenia, Fourth Edition (Fundamental and Clinical Cardiology)

Heparin-Induced Thrombocytopenia, Fourth Edition (Fundamental and Clinical Cardiology)
by Theodore E. Warkentin (Editor), Andreas Greinacher (Editor)


Although first reported in 1973, immune heparin-induced thrombocytopenia (HIT) remains one of the most potentially devastating and frequent adverse drug reactions encountered by physicians. This Fourth Edition reinforces its standing as the leading guide to the accurate diagnosis and management of HIT by identifying key signs and symptoms of this disorder and providing clear intervention strategies, including detailed information on the use of alternative anticoagulants to manage these critical circumstances. Intended for those requiring an expert source of guidance for the quick detection and control of HIT, this reference: contains new chapters on novel pharmacotherapies, recent drug approvals, current dosing guidelines, and the advantages and limitations of alternative...

Heparin-Binding Proteins

Heparin-Binding Proteins
by H. Edward Conrad (Author)


This book describes the complex structures of heparins and heparan sulfates (heparinoids) and how they are generated by their biosynthetic pathways. The book also details the methodologies for studying these structures and their cellular metabolism. Heparin-Binding Proteins introduces the general nature of interactions between heparinoids and proteins, and presents the role for these structures in their interactions with the proteins of the hemostatic mechanisms, fibroblasts growth factors, superoxide dismutase, and lipoproteins.

Key Features
* Covers cellular metabolism of heparinoid proteoglycans
* Written by a distinguished expert in the field of carbohydrate biochemistry
* Describes the roles of heparan sulfate proteoglycans...

Heparin - A Century of Progress (Handbook of Experimental Pharmacology)

Heparin - A Century of Progress (Handbook of Experimental Pharmacology)
by Rebecca Lever (Editor), Barbara Mulloy (Editor), Clive P. Page (Editor)


Heparins remain amongst the most commonly used drugs in clinical practice.  Almost 100 years have passed since the initial discovery of this complex substance and, during this time, understanding of the nature and uses of heparin and related molecules has grown dramatically. The aim of this volume is to summarise the developments that have led to the current status of both heparins as drugs and the field of heparin research, with a focus on the particularly rapid progress that has been made over the past three decades. Individual sections are dedicated to the nature of heparin as a biological molecule, the current approaches and techniques that are used to ensure the safety and reliability of heparin as a medicine, the clinical pharmacology of heparin as an anticoagulant drug, effects...

Heparin:: Properties, Uses and Side Effects (Pharmacology - Research, Safety Testing and Regulation)

Heparin:: Properties, Uses and Side Effects (Pharmacology - Research, Safety Testing and Regulation)
by David E. Piyathilake (Editor), Rhong Liang (Editor)


Book annotation not available for this title.
Title: Heparin:
Author: Piyathilake, David E. (EDT)/ Liang, Rhong (EDT)
Publisher: Nova Science Pub Inc
Publication Date: 2011/11/01
Number of Pages: 332
Binding Type: HARDCOVER
Library of Congress: 2011034014

Heparin: Structure, Cellular Functions, and Clinical Applications

Heparin: Structure, Cellular Functions, and Clinical Applications
by Norman M. McDuffie (Editor)




Chemistry and Biology of Heparin and Heparan Sulfate

Chemistry and Biology of Heparin and Heparan Sulfate
by Hari G. Garg (Editor), Robert J. Linhardt (Editor), Charles A. Hales (Editor)


The chemistry, biochemistry and pharmacology of heparin and heparan sulfate have been and continue to be a major scientific undertaking - heparin and its derivative remain important drugs in clinical practice. Chemistry and Biology of Heparin and Heparan Sulfate provides readers with an insight into the chemistry, biology and clinical applications of heparin and heparan sulfate and examines their function in various physiological and pathological conditions. Providing a wealth of useful information, no other tome covers the diversity of topics in the field. Students, doctors, chemists, biochemists, and research scientists will find this book an invaluable source for updating their current knowledge of developments in this area.

*...

Heparin: Structure, Drug Delivery Applications and Clinical Outcomes (Pharmacology-Research, Safety Testing and Regulations)

Heparin: Structure, Drug Delivery Applications and Clinical Outcomes (Pharmacology-Research, Safety Testing and Regulations)
by Nicole B. Wilkinson (Editor)




Mysterious Heparin, the Key to Open Heart Surgery

Mysterious Heparin, the Key to Open Heart Surgery
by McGraw-Hill Ryerson, Toronto, (Publisher)


One of the world's pioneering heart surgeons, Canada's W.G. Bigelow, explains the mysterious anticoagulant heparin, essential to open heart surgery, from its discovery at Johns Hopkins University in 1916 through its purification for human use, finally supplying the key that makes possible the definitive treatment of the most common cause of illness and death -- heart disease.

© 2014 BrightSurf.com